The JAK1/JAK2 ‐ inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release

Clinical&Experimental Allergy,Volume 0, Issue ja, -Not available-.

Source: Clinical and Experimental Allergy - June 25, 2018 Category: Allergy & Immunology Authors: M.A.W. Hermans , B. Schrijver , J.C.P.A. van Holten ‐Neelen , R. Gerth van Wijk , P.M. van Hagen , P.L.A. van Daele , W.A. Dik Source Type: research